Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
224.53B
Market cap224.53B
Price-Earnings ratio
12.07
Price-Earnings ratio12.07
Dividend yield
2.39%
Dividend yield2.39%
Average volume
8.34M
Average volume8.34M
High today
$51.23
High today$51.23
Low today
$49.63
Low today$49.63
Open price
$50.00
Open price$50.00
Volume
9.52M
Volume9.52M
52 Week high
$71.28
52 Week high$71.28
52 Week low
$35.12
52 Week low$35.12

NVO News

TipRanks 9h
Novo Nordisk’s ZEUS Trial Reaches Completion: What It Could Mean for NVO Investors

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

Nasdaq 12h
Where Will Novo Nordisk Stock Be in 3 Years?

Key Points Novo Nordisk remains a step behind Eli Lilly in the weight loss drug market. Its most promising programs might not be competitive with Lilly's. Th...

Where Will Novo Nordisk Stock Be in 3 Years?
TipRanks 2d
Novo Nordisk Boosts Treasury Stock as 2026 Share Buyback Passes DKK 7.1 Billion

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

57%

of 37 ratings
Buy
37.8%
Hold
56.8%
Sell
5.4%

More NVO News

The Motley Fool 4d
Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors?

GLP-1 drugs for weight loss are such a booming business that it was inevitable the major manufacturers of these wonder drugs would eventually end up in court. T...

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors?
TipRanks 4d
Novo Nordisk Pursues Injunction to Block Eli Lilly’s Advertisements

Novo Nordisk (NVO) has escalated its feud with rival drug maker Eli Lilly (LLY) by ​seeking a ​court injunction to immediately block Lilly’s weight-loss drug ad...

Seeking Alpha 5d
Novo files injunction to block Lilly’s weight-loss drug ads

Novo Nordisk (NVO) on Friday said it filed a preliminary injunction to immediately block Eli Lilly (LLY) from running obesity and diabetes drug advertisements i...

Novo files injunction to block Lilly’s weight-loss drug ads
Simply Wall St 5d
Novo Nordisk Faces A Fair Value Debate, Is The Stock A Bargain?

Novo Nordisk (NYSE:NVO) shares closed at US$48.18, with recent returns mixed, including a decline over the past week and gains over the past month and past 3 mo...

Novo Nordisk Faces A Fair Value Debate, Is The Stock A Bargain?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.